Statistics

Total Visits

Views
Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel28

Select a period of time:

Number of views in the range

Views
Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel15

Views

Views
October 20240
November 20240
December 20240
January 20250
February 20251
March 202514
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States1
 

Top cities views

Views